CLINICAL_TRIALS
trial_result
· 2012-03-26
Clinical Trial Update: A Safety Study of Pentoxifylline for the Treatment of Anemia [Phase 2]
Summary
A Phase 2 safety study of pentoxifylline for anemia in patients with end-stage renal disease was terminated, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fresenius Medical Care North America | Conditions: End Stage Renal Disease | Phase 2 | Status: TERMINATED | Results posted: 2012-03-26